tm logo
BOEHRINGER INGELHEIM BIOXCELLENCE
Live/Registered
PARTIAL SECTION 71 ACCEPTED

on 29 Sep 2023

Last Applicant/ Owned by

Binger Straße 173

Ingelheim

DE

55218

Serial Number

79127685 filed on 14th Sep 2012

Registration Number

4634652 registered on 11th Nov 2014

in the Principal Register

Correspondent Address

Max Moskowitz

Max Moskowitz Ostrolenk Faber LLP

New York, NY 10022

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

BOEHRINGER INGELHEIM BIOXCELLENCE

Scientific and technological services, namely, scientific research, analysis and testing of active substances, medicine and treatment in the field of biotechnology; research and development of new products for other sand scientific laboratory services in the field of biotechnology; performance of chemical, biochemical and biological analysis; development of biological, biotechnological and pharmac Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical and veterinary consulting; providing medical and veterinary information via the Internet; all the aforementioned consultations and services also provided through a database; providing medical information via the Internet


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, namely, scientific research, analysis and testing of active substances, medicine and treatment in the field of biotechnology; research and development of new products for other sand scientific laboratory services in the field of biotechnology; performance of chemical, biochemical and biological analysis; development of biological, biotechnological and pharmaceutical analysis and their application for others; technical and scientific consultancy, particularly in the field of biotechnology; scientific research; conducting clinical trials for others of pharmaceutical products; providing scientific information via the Internet in the field of pharmaceutical, health care and medical fields; scientific research consulting in the field of pharmaceutical, health care and medical fields


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [035]
Advertising, Business & Retail Services


Compilation of data in computer databases, in particular in the field of biotechnology and biopharmaceutics; management in connection with the commercialization of technical or scientific results; management relating to the organisation of research; creation, namely, writing and compiling of manufacturing and registration dossiers for pharmaceutical products for third parties; office work, namely, operation of registration proceedings for pharmaceutical products


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [016]
Paper Goods and Printed Material


Printed matter, namely, newspapers, photographs, magazines, books, printed periodicals, newsletters, and brochures all in the field of pharmaceutical preparations; paper; cardboard; goods made from paper and cardboard, namely, boxes of paper and cardboard boxes; cardboard packaging, namely, pharmaceutical packaging; patient record cards and prescription pads; in the field of in the fields of medicine and pharmaceuticals; printed teaching and instructional materials, namely, pharmaceutical information leaflets;books in the fields of medicine and pharmaceuticals; printed publications, namely, magazines, newsletters,pamphlets, reports, instructional and information leaflets, and posters in the fields of medicine and pharmaceuticals; paper packaging, namely, packaging containers of paper; stationery; printed instructional and teaching materials relating to the pharmaceutical, health care and medical fields, in the field of research, medicine, veterinary and laboratory techniques


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; preparations for destroying vermin; fungicides, herbicides; bacteriological cultures for medical and veterinary purposes as well as culture media for bacteriological cultures; bacteriological preparations for medical and veterinary use for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; biological preparations for medical and for veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; biochemical preparations for medical and veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; ferments for pharmaceutical purposes; vaccines; culture media for microorganisms; plasters and dressings for medical purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemical, biochemical and biological products, substances and preparations for industrial and scientific purposes as well as for research purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Custom manufacture of pharmaceuticals, pharmaceutical ingredients, chemical products and chemical intermediates as well as of biological and biochemical products for third parties; treatment of biological materials, namely, batch treatment services with respect to microorganisms and proteins


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [038]
Communications Services


Transmitting medical and scientific information by means of a database


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79127685

Mark Type

No Service Mark

Attorney Docket Number

No TE/3975-188

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th Oct 2024PARTIAL INVALIDATION PROCESSED BY THE IB
16th Jul 2024GENERIC MADRID TRANSACTION SENT TO IB
16th Jul 2024GENERIC MADRID TRANSACTION CREATED
14th Jun 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11th Nov 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
29th Sep 2023REGISTERED - PARTIAL SEC 71 ACCEPTED
29th Sep 2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
18th May 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
26th Nov 2022POST REGISTRATION ACTION MAILED - SEC.71
18th Nov 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED